| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | NUR3DD000112 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | NUR3DD000112 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R21OH012386 | Reducing Psychological Distress in Fire Fighters with an Asynchronous App-based Meditation Intervention | 02 | 2 | CDC | 11/13/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | NUR3DD000112 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 3 | CDC | 11/10/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721-0158 | PIMA | USA | R21OH012386 | Reducing Psychological Distress in Fire Fighters with an Asynchronous App-based Meditation Intervention | 02 | 2 | CDC | 11/13/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $205,422,514 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | U01AI187043 | A Novel RAD51-BRCA2 Complex Stabilizing Drug: A Medical Countermeasure for Mitigating Accidental Radiation Exposure | 000 | 1 | NIH | 9/16/2025 | $583,468 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL075619 | Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies | 001 | 21 | NIH | 7/23/2025 | $56,978 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL075619 | Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies | 000 | 21 | NIH | 11/20/2024 | $512,798 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21AI181603 | Ionic liquid-based nanoemulsion containing combination antiretroviral drugs for the oral and transdermal treatment of HIV infection | 000 | 2 | NIH | 8/6/2025 | $193,125 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL141174 | Transcriptional Regulation of Endothelial Cells after Neonatal Lung Injury | 001 | 7 | NIH | 7/18/2025 | $666,314 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01ES034690 | In Vitro to In Vivo Extrapolation of Toxicant Effects on Ovarian Function | 000 | 2 | NIH | 1/28/2025 | $740,816 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA268383 | Targeting Lysosomal Vulnerabilities in Renal Pathogenesis | 001 | 4 | NIH | 5/22/2025 | $48,083 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA268383 | Targeting Lysosomal Vulnerabilities in Renal Pathogenesis | 000 | 4 | NIH | 2/14/2025 | $432,750 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | U01AG082617 | PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study | 001 | 3 | NIH | 8/19/2025 | $1,990,623 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31MD018943 | Pathways linking childhood and intergenerational trauma at the US-Mexico border with cardiovascular health. | 003 | 2 | NIH | 7/28/2025 | $8,244 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | AY2AX000090 | Game Changing Quantitative and Targeted Multimodal Lymphatic Imaging to Go | 000 | 1 | NIH | 9/24/2025 | $1,007,112 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | AY2AX000090 | Game Changing Quantitative and Targeted Multimodal Lymphatic Imaging to Go | 000 | 1 | NIH | 9/24/2025 | $769,806 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01EY036247 | Repurposing and reformulation of adefovir dipivoxil for improved topical treatment of herpes simplex virus infection of the eye | 001 | 2 | NIH | 8/4/2025 | $639,940 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R00CA267163 | Cognitive Science to Radiology: Using EEG and Eye-tracking to Determine Why, How, and When Novices and Radiologists Miss Signs of Breast Cancer in Multiple-abnormality Mammography and Tomosynthesis | 000 | 3 | NIH | 12/16/2024 | $221,628 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | RF1AG093527 | Optimizing semantic memory measures of Alzheimer's disease biomarkers | 000 | 1 | NIH | 9/25/2025 | $3,030,409 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA272487 | A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy | 001 | 3 | NIH | 5/22/2025 | $34,408 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01CA272487 | A Phospholipid-Derived Nanotherapeutic Platform for Improved Colorectal Cancer Immunochemotherapy | 000 | 3 | NIH | 3/18/2025 | $309,672 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | K01HL181331 | Translational Light-Based Intervention Strategies for Improving Sleep and Circadian Health in Early Childhood | 000 | 1 | NIH | 7/23/2025 | $172,085 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | UG3CA290443 | Investigating novel targets for topical immunoprevention of keratinocytic skin cancer | 000 | 1 | NIH | 7/30/2025 | $462,092 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R35GM156786 | Uncovering how chaperones assist in protein folding and preventing toxic protein aggregates | 000 | 1 | NIH | 7/28/2025 | $272,596 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31NS141379 | Characterizing clearance mechanisms of TDP-43 and disease associated isoforms | 001 | 1 | NIH | 7/31/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | DP2HD121942 | Response-contingent learning to modulate synaptic plasticity for spinal cord injury | 000 | 1 | NIH | 7/23/2025 | $1,384,314 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31NS141379 | Characterizing clearance mechanisms of TDP-43 and disease associated isoforms | 000 | 1 | NIH | 7/31/2025 | $49,538 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | OT2OD037642 | University of Arizona-Banner Health Mountain Consortium | 001 | 1 | NIH | 8/13/2025 | $500,000 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | OT2OD037642 | University of Arizona-Banner Health Mountain Consortium | 001 | 1 | NIH | 8/13/2025 | $1,050,000 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | OT2OD037642 | University of Arizona-Banner Health Mountain Consortium | 001 | 1 | NIH | 8/13/2025 | $1,000,000 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD109310 | The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus | 001 | 3 | NIH | 4/14/2025 | $38,375 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HD109310 | The role of Alpha1-Adrenergic Receptors Promoter Methylation in Cerebral Autoregulation in Fetus | 000 | 3 | NIH | 3/3/2025 | $345,375 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DK124501 | Dissecting a central amygdala-parasubthalamic nucleus circuitry underlying appetite control | 001 | 5 | NIH | 5/21/2025 | $37,507 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DK124501 | Dissecting a central amygdala-parasubthalamic nucleus circuitry underlying appetite control | 000 | 5 | NIH | 2/21/2025 | $337,554 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS123424 | Control of the time course of dopamine release through optimized electrical brain stimulation. | 001 | 2 | NIH | 2/13/2025 | $256,934 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS123424 | Control of the time course of dopamine release through optimized electrical brain stimulation. | 002 | 3 | NIH | 8/18/2025 | $256,934 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31AR085369 | Defining the relationship between titin segment A168-170 and the E3 ligase MuRF1 in skeletal muscle atrophy | 001 | 1 | NIH | 8/20/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL177566 | Hepatocyte TMEM141 in Lipoprotein Metabolism | 000 | 1 | NIH | 7/15/2025 | $744,453 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | F31AR085369 | Defining the relationship between titin segment A168-170 and the E3 ligase MuRF1 in skeletal muscle atrophy | 000 | 1 | NIH | 8/14/2025 | $49,538 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R21AI191389 | Advancing a Platform Technology for C. difficile Infection Treatment: the Promise of Antisense Oligonucleotides | 000 | 1 | NIH | 7/14/2025 | $426,875 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL180711 | Role of hexokinase 3 in macrophage polarization and cardiac remodeling after myocardial infraction. | 000 | 1 | NIH | 8/13/2025 | $676,459 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01HL179683 | Selective Targeting of Alveolar Capillaries in Neonatal Lung Injury | 000 | 1 | NIH | 8/17/2025 | $730,070 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01DC021686 | The genomic and epigenomic landscape of otosclerosis | 000 | 1 | NIH | 3/12/2025 | $533,978 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01NS124222 | Regenerative Ultramicroelectrode arrays for sensory-motor specific interfacing | 001 | 5 | NIH | 6/27/2025 | $559,393 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R01AG087952 | TDP-43 LLPS and mitochondrial dysfunction in neurodegeneration | 000 | 1 | NIH | 7/23/2025 | $638,682 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R37AG053589 | Aging and Estrogenic Control of the Bioenergetic System in Brain | 001 | 9 | NIH | 6/18/2025 | $42,979 |
| | 2025 | 2025 | UNIVERSITY OF ARIZONA | 845 N PARK AVE RM 538 | TUCSON | AZ | 85721 | PIMA | USA | R37AG053589 | Aging and Estrogenic Control of the Bioenergetic System in Brain | 000 | 9 | NIH | 3/13/2025 | $483,526 |
|
